Abstract

The dopaminergic hypothesis of schizophrenia is the main concept explaining the direct reasons of schizophrenia and the effectiveness of current antipsychotics. All antipsychotics present on the market are potent dopamine D2 receptor antagonists or partial agonists. In this work we investigate a series of dopamine D2 receptor antagonists which do not fulfill the criteria of the classical pharmacophore model as they do not possess a protonatable nitrogen atom necessary to interact with the conserved Asp(3.32). Such compounds are interesting, inter alia, due to possible better pharmacokinetic profile when compared to basic, ionizable molecules. By means of homology modeling, molecular docking and molecular dynamics we determined that the compounds investigated interact with Asp(3.32) via their amide nitrogen atom. It was found that the studied compounds stabilize the receptor inactive conformation through the effect on the ionic lock, which is typical for GPCR antagonists. We constructed a CoMFA model for the studied compounds with the following statistics: R2 = 0.95, Q2 = 0.63. The quality of the CoMFA model was confirmed by high value of R2 of the test set, equal 0.96. The CoMFA model indicated two regions where bulky substituents are favored and two regions where bulky substituents are not beneficial. Two red contour regions near carbonyl groups were identified meaning that negative charge would be favored here. Furthermore, the S-oxide group is connected with blue contour region meaning that positive charge is favored in this position. These findings may be applied for further optimization of the studied compound series.

Highlights

  • G protein-coupled receptors (GPCRs) account for approximately 30% of all current drug targets (Overington et al 2006; Komatsu 2015)

  • We studied the interactions of these dopamine D2 receptor antagonists without a protonatable nitrogen atom with the dopamine D2 receptor by means of homology modeling, molecular docking and molecular dynamics and we constructed a CoMFA model for them which can enable further modifications within this series of compounds

  • The model was based on molecular alignment derived from molecular docking to the orthosteric site of the dopamine D2 receptor homology model

Read more

Summary

Introduction

G protein-coupled receptors (GPCRs) account for approximately 30% of all current drug targets (Overington et al 2006; Komatsu 2015). Medicinal Chemistry Research (2018) 27:1149–1166 neurons and by drugs that selectively interact with neuronal dopamine receptors (Missale et al 2010). These symptoms include rigidity in Parkinson’s disease, dyskinesia in Huntington’s disease, spontaneous oral dyskinesia in the elderly and hallucinations in Alzheimer’s disease and schizophrenia (Missale et al 2010). The dopaminergic hypothesis of schizophrenia is the main concept explaining the direct reasons for schizophrenia and the effectiveness of current antipsychotics. According to this hypothesis the pathomechanism of schizophrenia is attributed to the dysfunction of dopaminergic receptors in the mesolimbic system (positive symptoms) and mesocortical pathway (negative symptoms)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call